Neurocrine Biosciences (NASDAQ:NBIX)
- Dollar Amount of Shares Sold
- $60,122,120.48
- Number of Insider Stock Sales in the Last 180 Days
- 35
- Volume of Shares Sold
- 452,451
- Who Sold Shares
- Darin Lippoldt (Insider), David W Boyer (Insider), Eiry Roberts (Insider), Eric Benevich (Insider), Gary A Lyons (Director), George J Morrow (Director), Ingrid Delaet (Insider), Jude Onyia (Insider), Kevin Charles Gorman (CEO), Kyle Gano (Insider), Leslie V Norwalk (Director), Matt Abernethy (CFO), Richard F Pops (Director) and William H Rastetter (Director)
About Neurocrine Biosciences
Neurocrine Biosciences, Inc discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
Read More
